{
    "2018-01-27": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Stocks I'm Never Selling",
                "features": {
                    "keywords": [
                        "stocks",
                        "never selling"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie Gives More Juice to Drug Rally",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "drug rally"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie Says Tax Overhaul Will Slash 2018 Effective Tax Rate to 9%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "tax overhaul",
                        "effective tax rate"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "AbbVie wins U.S. trial in lawsuit over AndroGel's risks",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "U.S. trial",
                        "lawsuit",
                        "AndroGel"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Donâ€™t Chase AbbVie Inc Stock After Its Huge Earnings Win",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings win"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "5 Biotech and Pharmaceutical Stocks Going Bonkers",
                "features": {
                    "keywords": [
                        "biotech",
                        "pharmaceutical stocks",
                        "bonkers"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}